After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Putin is busy in war with Ukraine, Imran Khan had to return to Pakistan without meeting
Russian troops have started attacking Ukraine following the orders of Russian President Vladimir
Severe heat wave conditions are prevailing in various states of North and Central India. The temp
Munmun Dutta: Supreme Court's relief to Babita ji of 'Taarak Mehta Ka Ooltah Chashmah'
Babita i.e. Munmun Dutta of TV's famous serial 'Taarak Mehta Ka Ooltah Chashmah' got relief from
Gurguram Vaccination - People Still in line for 12 hours still not vaccinated
The situation of Gurugram, which occupies the first position in the state by putting 19 lakh dose
IPL 2024: Fans booed Hardik in Wankhede, Rohit stopped him and was seen pacifying the audience.
The 17th season of IPL has been full of bad memories for Hardik Pandya so far. On one hand, the t
Sri Lanka, which is facing an economic crisis, announced on Tuesday that it will not repay the fo
While the issue of seeking an interim stay on the Waqf Amendment Act 2025 is pending in the Supre
The discovery of a new antibiotic drug could save nearly 7 million lives lost to superbugs every
The wonders of the Indian Air Force are often seen. But today the Air Force has done something th
The series of G-20 meetings under the chairmanship of India has started. Heads of the world's top
